Spotlight -

Introducing PsychiatryLive!|

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Guidelines

CME Content

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

Please check back later for more content.

Trending on Psychiatric Times

Dementia and the Tuberculosis Vaccine: Reduced Tau Burden With Administration in Mice

GLP-1 Receptor Agonists May Reinforce Restriction in Patients With Eating Disorders

ALKS 7290 for Adjunctive Treatment for MDD Enters Phase 2 Study

October 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News

Titrating ADHD Medication to an Optimal Dose